Survival Analysis of Diabetic Colorectal Cancer Patients on Metformin
Metformin, an antihyperglycemic drug, has been associated with antineoplastic effects and could potentially improve colorectal cancer prognosis. The association between metformin and colorectal cancer prognosis has shown conflicting results. This study aims to define the association between metform...
Saved in:
Main Authors: | Alex Brandon Wong, Ravi Patnaik, Li Ling Chaw, Shir Kiong Lu, Long Chiau Ming, Wen Han Chooi, Ya Chee Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
HH Publisher
2023-12-01
|
Series: | Progress in Microbes and Molecular Biology |
Online Access: | https://journals.hh-publisher.com/index.php/pmmb/article/view/919 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
by: Fanqiang Meng, et al.
Published: (2017-01-01) -
Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
by: Yaodu Wang, et al.
Published: (2017-01-01) -
Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01) -
Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma
by: Hsiang Ying Lee, et al.
Published: (2025-01-01) -
Efficacy of chlorine dioxide as a disinfectant
by: Shermaine Yee, et al.
Published: (2020-10-01)